Patent details
EP2056829 Title: USING PI3K AND MEK MODULATORS IN TREATMENTS OF CANCER
Basic Information
- Publication number:
- EP2056829
- PCT Application Number:
- PCT/US/2007/018057
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP078113446
- PCT Publication Number:
- WO/2008/021389
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USING PI3K AND MEK MODULATORS IN TREATMENTS OF CANCER
- French Title of Invention:
- PROCÉDÉS D'UTILISATION DE MODULATEURS PI3K ET MEK
- German Title of Invention:
- VERWENDUNG VON PI3K- UND MEK-MODULATOREN BEI DER KREBSBEHANDLUNG
- SPC Number:
Dates
- Filing date:
- 16/08/2007
- Grant date:
- 04/01/2012
- EP Publication Date:
- 04/01/2012
- PCT Publication Date:
- 21/02/2008
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 13/05/2009
- EP B1 Publication Date:
- 04/01/2012
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 16/08/2012
- Expiration date:
- 16/08/2027
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 30/12/2011
- Name:
- Exelixis Inc.
- Address:
- 210 East Grand Avenue, South San Francisco, CA 94080, United States (US)
Inventor
1
- Name:
- MARTINI Jean-Francois, A.
- Address:
- United States (US)
2
- Name:
- AFTAB Dana, T.
- Address:
- United States (US)
3
- Name:
- LAIRD A., Douglas
- Address:
- United States (US)
4
- Name:
- LAMB Peter
- Address:
- United States (US)
Priority
- Priority Number:
- 838307 P
- Priority Date:
- 16/08/2006
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/498;
| Filing date | Document type | Number of pages |
|---|